Skip to main content

FOXO TECHNOLOGIES INC.

For the period ended Mar 31, 2026. Filed May 15, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 15, 2026

FOXO$0.13+19.2%Stored close · as of Jul 8, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Financial Statements Unaudited Condensed Consolidated Balance Sheets as of March 31, 2026 and December 31, 2025

ITEM 1. FINANCIAL STATEMENTS

FOXO technologies inc. and subsidiaries

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

March 31,December 31,
20262025
Assets
Current assets
Cash and cash equivalents$65,896$207,453
Accounts receivable, net3,910,4232,468,346
Inventory and supplies188,565183,627
Prepaid expenses122,74897,691
Other current assets200,208155,363
Total current assets4,487,8403,112,480
Property and equipment, net303,544322,357
Intangible assets, net9,777,0419,770,969
Goodwill27,794,97527,823,444
Right-of-use assets3,422,7343,548,623
Total assets$45,786,134$44,577,873
Liabilities and Stockholders’ Equity
Current liabilities
Accounts payable$7,480,588$6,966,211
Accrued expenses12,787,23211,902,383
Notes payable3,208,8192,151,838
Related parties’ notes and loans payable5,318,8224,902,392
Other loans82,236237,810
Related parties’ payables and accrued expenses2,150,4151,998,775
Right-of-use lease obligations534,660499,351
Total current liabilities31,562,77228,658,760
Contingent purchase price consideration500,000500,000
Right-of-use lease obligations, non-current3,027,9773,174,549
Medicare cost report settlement payables1,059,2711,168,264
Total liabilities36,150,02033,501,573
Commitments and contingencies (Note 14)-
Stockholders’ equity (deficit)
Series A preferred stock, $0.0001 par value and $1,000 stated value per share; 50,000 shares authorized, 19,233 and 19,342 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively22
Series B preferred stock, $0.0001 par value and $1,000 stated value per share; 7,500 shares authorized, 3,245 shares issued and outstanding as of March 31, 2026 and December 31, 2025--
Series C preferred stock, $0.0001 par value and $1,000 stated value per share; 5,000 shares authorized, 304 shares issued and outstanding as of March 31, 2026 and December 31, 2025--
Series D preferred stock, $0.0001 par value and $1,000 stated value per share; 10,000 shares authorized, 4,312 issued and outstanding as of March 31, 2026 and December 31, 202511
Series E preferred stock, $0.0001 par value and $25 stated value per share; 4,000,000 shares authorized, 68,000 shares issued and outstanding as of March 31, 2026 and December 31, 202577
Class A common stock, $0.0001 par value, 10,000,000,000 shares authorized, 3,732,660,151 and 2,495,660,151 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively373,266249,566
Additional paid-in-capital235,431,445235,540,145
Accumulated deficit(226,096,712)(224,644,739)
Total FOXO’s stockholders’ equity9,708,00911,144,982
Noncontrolling interest(71,895)(68,682)
Total stockholders’ equity9,636,11411,076,300
Total liabilities and stockholders’ equity$45,786,134$44,577,873

Foxo Technologies INc. and subsidiaries

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.